Search research articles
Contact Us
Filters
Showing results (61-70 of 187) with videos related to
Page
of 19
Sort By:
Pharmaceutics
|
March 26, 2022
<i>Withania somnifera</i>: Progress towards a Pharmaceutical Agent for Immunomodulation and Cancer Therapeutics
Vivek K Kashyap, Godwin Peasah-Darkwah, Anupam Dhasmana, et al.
ACS Applied Bio Materials
|
February 18, 2022
<i>In Situ</i> Nanoparticle Self-Assembly for Combination Delivery of Therapeutics to Non-Small Cell Lung Cancer
Elham Hatami, Prashanth K B Nagesh, Neeraj Chauhan, et al.
Anticancer Research
|
April 19, 2011
Biotinylated PAMAM dendrimers for intracellular delivery of cisplatin to ovarian cancer: role of SMVT
Venkata K Yellepeddi, Ajay Kumar, Diane M Maher, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine
|
August 6, 2015
Approach for chemosensitization of cisplatin-resistant ovarian cancer by cucurbitacin B
Fardous F El-Senduny, Farid A Badria, Ahmed M El-Waseef, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association
|
August 18, 2018
Transmembrane mucin MUC13 distinguishes intraductal papillary mucinous neoplasms from non-mucinous cysts and is associated with high-risk lesions
Zachary E Stiles, Sheema Khan, Kurt T Patton, et al.
Pharmaceuticals (Basel, Switzerland)
|
April 13, 2018
Antibody-Drug Conjugates for Cancer Therapy: Chemistry to Clinical Implications
Nirnoy Dan, Saini Setua, Vivek K Kashyap, et al.
Cell Stress & Chaperones
|
December 5, 2015
Structural studies of UBXN2A and mortalin interaction and the putative role of silenced UBXN2A in preventing response to chemotherapy
Sanam Sane, Ammara Abdullah, Morgan E Nelson, et al.
Journal of Ovarian Research
|
August 8, 2024
Emerging role of mucins in antibody drug conjugates for ovarian cancer therapy
Shabnam Malik, Mohammed Sikander, Natasha Bell, et al.
Immunotherapy
|
February 21, 2022
A global picture: therapeutic perspectives for COVID-19
Vivek P Chavda, Carron Kapadia, Shailvi Soni, et al.
Biomaterials
|
December 21, 2010
Multi-functional magnetic nanoparticles for magnetic resonance imaging and cancer therapy
Murali M Yallapu, Shadi F Othman, Evan T Curtis, et al.
Page
of 19
Search research articles
Search
Showing results (61-70 of 187) with videos related to
Sort By:
Page
of 19
Pharmaceutics
|
March 26, 2022
<i>Withania somnifera</i>: Progress towards a Pharmaceutical Agent for Immunomodulation and Cancer Therapeutics
Vivek K Kashyap, Godwin Peasah-Darkwah, Anupam Dhasmana, et al.
ACS Applied Bio Materials
|
February 18, 2022
<i>In Situ</i> Nanoparticle Self-Assembly for Combination Delivery of Therapeutics to Non-Small Cell Lung Cancer
Elham Hatami, Prashanth K B Nagesh, Neeraj Chauhan, et al.
Anticancer Research
|
April 19, 2011
Biotinylated PAMAM dendrimers for intracellular delivery of cisplatin to ovarian cancer: role of SMVT
Venkata K Yellepeddi, Ajay Kumar, Diane M Maher, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine
|
August 6, 2015
Approach for chemosensitization of cisplatin-resistant ovarian cancer by cucurbitacin B
Fardous F El-Senduny, Farid A Badria, Ahmed M El-Waseef, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association
|
August 18, 2018
Transmembrane mucin MUC13 distinguishes intraductal papillary mucinous neoplasms from non-mucinous cysts and is associated with high-risk lesions
Zachary E Stiles, Sheema Khan, Kurt T Patton, et al.
Pharmaceuticals (Basel, Switzerland)
|
April 13, 2018
Antibody-Drug Conjugates for Cancer Therapy: Chemistry to Clinical Implications
Nirnoy Dan, Saini Setua, Vivek K Kashyap, et al.
Cell Stress & Chaperones
|
December 5, 2015
Structural studies of UBXN2A and mortalin interaction and the putative role of silenced UBXN2A in preventing response to chemotherapy
Sanam Sane, Ammara Abdullah, Morgan E Nelson, et al.
Journal of Ovarian Research
|
August 8, 2024
Emerging role of mucins in antibody drug conjugates for ovarian cancer therapy
Shabnam Malik, Mohammed Sikander, Natasha Bell, et al.
Immunotherapy
|
February 21, 2022
A global picture: therapeutic perspectives for COVID-19
Vivek P Chavda, Carron Kapadia, Shailvi Soni, et al.
Biomaterials
|
December 21, 2010
Multi-functional magnetic nanoparticles for magnetic resonance imaging and cancer therapy
Murali M Yallapu, Shadi F Othman, Evan T Curtis, et al.
Page
of 19